Week in Review, July 8–12

Editor accused of fraud leaves post; the good and the bad of gut microbiota; bacterial gene shuffle; legal restrictions hamper illicit drug research; antibodies and autism

Written byJef Akst
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

FLICKR, JOHN MARTINEZ PAVLIGALast week, The Scientist reported that Dmitry Kuznetsov, a Russian biochemist with a long history of fraud allegations, had taken the role as chief editor of two new journals launched in 2011. The misconduct accusations against Kuznetsov, if true, amount to “one of the worst fraud records in the history of science,” said Dan Larhammar, a professor at Uppsala University in Sweden who has written about problems in Kuznetsov's work. “That should be a major concern to” the publisher that recruited Kuznetsov as editor-in-chief, he said.

This week, Kuznetsov sent reporter Kerry Grens a series of emails between himself and Manisha Basu, an editor at the journals’ publisher, ScienceDomain International, which revealed that Kuznetsov was leaving his posts. Still, the biochemist denies any wrongdoing, even offering explanations for why researchers had been unable to replicate his results or had trouble locating some of the allegedly “missing” papers cited in his publications.

WIKIMEDIA, CDCTwo new studies out this week tell an interesting story about the microbes that inhabit our gastrointestinal tracts: certain microbes in the colon may speed disease progression in HIV patients; and select strains of Clostridium bacteria proved beneficial in mouse models of colitis and allergy. HIV patients on antiretroviral treatment harbored variable gut microbial communities, some quite similar to healthy individuals and others more similar to untreated patients, whose microbiomes harbored a greater proportion of members of the Proteobacteria family and fewer members of Clostridia and Bacteroidia families. Interestingly, the more abnormal a patient’s microbiome, the greater immune cell activity and the higher the levels of inflammatory molecules in their blood. The researchers suspect that viral replication in the mucosa of the intestines can weaken the barrier, allowing the peaceful microbial inhabitants of the gut to leak into the surrounding tissues, causing inflammation and the proliferation of the immune cells that are susceptible to HIV infection.

In the second study, the researchers built on previous findings that germ-free mice treated with a cocktail of a few dozen strains of Clostridia promoted the activity of regulatory T cells (Treg) in the colon, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies